Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. chil. reumatol ; 21(2): 58-64, 2005. graf
Artículo en Español | LILACS | ID: lil-432947

RESUMEN

Autoinmune diseases occur when the immunological system loses its capability to recognize between self and foreign, and develops a response against healthy tissues. Both molecular bases that trigger these pathologies and genetic factors of susceptibility are unknown. Identification of these factors is fundamental for understanding and developing specific therapies for autoimmune diseases. Dendritic cells (DCs) - professional antigen presenting cells - play a fundamental roll in the development and modulation of the acquired immune response because they have the unique capacity to active naïve T lymphocytes. In order to activate T lymphocytes, the DCs must supply simultaneously two molecular signals which correspond to the antigen (or peptid complex MHC) plus costimulating signals. In absence of costimulation, the DCs induce inactivation of T lymphocytes, mechanism by which they are able to maintain peripheral tolerance against self antigens. In this way, it has been proposed that the immature DCs present antigens in absence of costimulation and provoke tolerance. On the contrary, mature DCs present antigens together with costimulating signals, which lead to immunity. In self-immune diseases, the process of tolerance in the presence of autoantigens could be deficient due to alterations in the normal function of DCs. One of the causes of this defect could be that there is an unbalance in the expression of activating and inhibiting Fcy receptors on the surface of DCs. This would generate DCs with a constitutive phenotype of maturity that would interfere with its tolerogenic activity, and would favor the permanent activation of T lymphocytes, including those that are autoreactive.


Asunto(s)
Humanos , Autoinmunidad , Activación de Linfocitos/fisiología , Células Dendríticas/inmunología , Inmunidad Celular/fisiología , Presentación de Antígeno , Activación de Linfocitos/inmunología , Enfermedades Autoinmunes/etiología , Linfocitos T/inmunología , Tolerancia Inmunológica/fisiología
2.
Rev. méd. Chile ; 132(3): 371-380, mar. 2004. ilus
Artículo en Español | LILACS | ID: lil-384181

RESUMEN

The important role that T lymphocytes play during the immune response against pathogens and tumor cells has encouraged the development of technologies aimed to detect these immune cells in an antigen-specific fashion. Recently, a methodology consisting of the production of soluble ligands that bind the T lymphocyte receptor was developed. Such ligands consist of molecules from the Major Histocompatibility Complex loaded with either pathogen or tumor derived peptides. These molecular complexes are tetramerized to enhance the binding efficiency to the T cell receptor (TCR), which improves the detection sensitivity of antigen specific T lymphocytes. This new technology is currently used successfully during the follow up patients that were vaccinated against certain tumor antigens, to evaluate the expansion of tumor specific T lymphocytes. This methodology is also promising for the detection and specific deletion of autoreactive T lymphocytes as a treatment for autoimmune disorders. In this article we review the molecular components involved in antigen recognition by T lymphocytes, and the potential benefits for Biomedicine that could result from the detection of these cells by soluble specific ligands (Rev MÚd Chile 2004; 132: 371-80).


Asunto(s)
Humanos , Linfocitos T , Linfocitos T/inmunología , Inmunidad Celular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA